Amylin Pharmaceuticals, Inc. · San Diego, CA United States (NASDAQ: AMLN)
| 9360 Towne Centre Dr. | Phone: 858-552-2200 |
| San Diego, CA | Fax: 858-552-2212 |
| 92121 | |
| United States | 
Map This Company |
Amylin Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets injectable diabetes drugs Byetta and Symlin, which are approved as adjunct therapies to other diabetes treatments such as metformin and insulin. Byetta is also approved as a stand-alone diabetes therapy. Amylin gained
Amylin Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: AMLN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 1,400 |
Executives
124 executives listed for Amylin Pharmaceuticals, Inc.'s San Diego, CA location.
| Chairman | Paulo Costa | |
|---|---|---|
| President, CEO, and Director | Daniel Bradbury | |
| SVP Operations | Paul Marshall |